drugset / Trial / NCT07445451

Magnesium vs. Dexmedetomidine in TURBT Under Spinal Anesthesia

NCT07445451

RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized controlled trial evaluated the effects of intraoperative intravenous magnesium sulfate versus dexmedetomidine on postoperative pain, analgesic consumption, hemodynamic stability, and respiratory function in patients undergoing elective transurethral resection of bladder tumor (TUR-M) under spinal anesthesia. Magnesium sulfate significantly reduced postoperative pain scores, delayed the time to first analgesic request, and decreased total analgesic consumption compared to dexmedetomidine and control groups, while both agents were hemodynamically and respiratorily safe.

Timeline

Start
2024-12-15
Primary completion
2025-09-01
Completion
2025-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Subject Magnesium Sulfate Other / unclassified 15 mg/kg Intravenous